TXMD

TherapeuticsMD, Inc.

2.02 USD
+0.21 (+11.60%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

TherapeuticsMD, Inc. stock is down -5.61% since 30 days ago. The next earnings date is Jul 9, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 61.54% of the previous 12 June’s closed higher than May.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone. It also manufactures and distributes branded and generic prescription prenatal vitamins.